- Report
- March 2024
- 183 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- May 2024
- 89 Pages
Global
From €5379EUR$5,600USD£4,631GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- January 2024
- 200 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- April 2019
- 153 Pages
Global
From €1321EUR$1,375USD£1,137GBP
€2641EUR$2,750USD£2,274GBP
- Report
- December 2022
- 117 Pages
Global
From €5715EUR$5,950USD£4,920GBP
- Report
- August 2023
- 74 Pages
Egypt
From €3362EUR$3,500USD£2,894GBP
- Report
- November 2020
- 155 Pages
Asia Pacific
From €2017EUR$2,100USD£1,736GBP
€2881EUR$3,000USD£2,481GBP
- Report
- September 2021
- 105 Pages
Global
From €4754EUR$4,950USD£4,093GBP
- Report
- February 2021
- 90 Pages
Global
€21130EUR$22,000USD£18,192GBP
- Book
- March 2020
- 281 Pages
- Book
- November 2013
- 320 Pages
End Stage Renal Disease (ESRD) is a medical condition in which the kidneys are no longer able to adequately filter waste from the blood. It is a major cause of morbidity and mortality in the U.S. and is managed by Urologists and Nephrologists. Treatment options for ESRD include dialysis, kidney transplantation, and conservative management. Dialysis is the most common treatment for ESRD and is used to replace the function of the kidneys. Kidney transplantation is the most effective treatment for ESRD, but is limited by the availability of donor organs. Conservative management is used to slow the progression of ESRD and improve quality of life.
The ESRD market is a rapidly growing sector of the healthcare industry. It is driven by an aging population, increasing prevalence of chronic kidney disease, and advances in dialysis technology. Companies in the ESRD market include Fresenius Medical Care, DaVita, Baxter International, NxStage Medical, and B. Braun Melsungen. Show Less Read more